BG36939A3 - Method for preparing macrolide - Google Patents

Method for preparing macrolide

Info

Publication number
BG36939A3
BG36939A3 BG054108A BG5410881A BG36939A3 BG 36939 A3 BG36939 A3 BG 36939A3 BG 054108 A BG054108 A BG 054108A BG 5410881 A BG5410881 A BG 5410881A BG 36939 A3 BG36939 A3 BG 36939A3
Authority
BG
Bulgaria
Prior art keywords
macrolide
preparing
preparing macrolide
formulated
point
Prior art date
Application number
BG054108A
Other languages
Bulgarian (bg)
English (en)
Inventor
Richard Baltz
Herbert Kirst
Gene Wild
Eugene Seno
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of BG36939A3 publication Critical patent/BG36939A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/54—Streptomyces fradiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/896—Streptomyces fradiae

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BG054108A 1980-11-10 1981-11-10 Method for preparing macrolide BG36939A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/205,539 US4304856A (en) 1980-11-10 1980-11-10 Process for producing 20-dihydro-20-deoxy-23-demycinosyltylosin

Publications (1)

Publication Number Publication Date
BG36939A3 true BG36939A3 (en) 1985-02-15

Family

ID=22762621

Family Applications (1)

Application Number Title Priority Date Filing Date
BG054108A BG36939A3 (en) 1980-11-10 1981-11-10 Method for preparing macrolide

Country Status (22)

Country Link
US (1) US4304856A (fr)
EP (1) EP0052005B1 (fr)
JP (1) JPS57108097A (fr)
KR (1) KR850001666B1 (fr)
AR (1) AR227563A1 (fr)
AU (1) AU7731381A (fr)
BG (1) BG36939A3 (fr)
CA (1) CA1169374A (fr)
CS (1) CS236663B2 (fr)
DD (1) DD202032A5 (fr)
DE (1) DE3168693D1 (fr)
DK (1) DK494381A (fr)
FI (1) FI813527L (fr)
GB (1) GB2086902B (fr)
GR (1) GR75386B (fr)
HU (1) HU190360B (fr)
IE (1) IE51826B1 (fr)
IL (1) IL64240A (fr)
PH (1) PH17375A (fr)
PL (1) PL233747A1 (fr)
PT (1) PT73947B (fr)
ZA (1) ZA817718B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419508A (en) * 1980-11-10 1983-12-06 Eli Lilly And Company 20-Dihydro-20-deoxy-23-demycinosyltylosin and process for its production
AU551142B2 (en) * 1981-07-09 1986-04-17 Zaidan Hojin Biseibutsu Kagaku Kenkyukai Tylosin derivatives
US4423148A (en) * 1982-07-02 1983-12-27 Eli Lilly And Company Process for producing 20-dihydro-20-deoxy-23-de(mycinosyloxy)tylosin
US4528369A (en) * 1982-07-02 1985-07-09 Eli Lilly And Company 20-Dihydro-20-deoxy-23-de(mycinosyloxy)tylosin
US4452784A (en) * 1982-07-19 1984-06-05 Eli Lilly And Company C-23-Modified derivatives of DMT
US4443436A (en) * 1982-09-13 1984-04-17 Eli Lilly And Company C-20-Modified macrolide derivatives of the macrolide antibiotics tylosin, desmycosin, macrocin, and lactenocin
IL71032A0 (en) * 1983-02-28 1984-05-31 Lilly Co Eli C-20 and c-23-modified macrolide derivatives
US4468511A (en) * 1983-02-28 1984-08-28 Eli Lilly And Company C-20- And C-23-Modified macrolide derivatives
US4629786A (en) * 1983-02-28 1986-12-16 Eli Lilly And Company C-20- and C-23 modified macrolide derivatives
WO1995002594A1 (fr) * 1993-07-15 1995-01-26 Pfizer Inc. Derives d'amides de macrolides antibiotiques a noyau de 16 elements
US6362009B1 (en) 1997-11-21 2002-03-26 Merck & Co., Inc. Solid phase synthesis of heterocycles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178341A (en) * 1960-06-27 1965-04-13 Lilly Co Eli Antibiotics tylosin and desmycosin and derivatives thereof
US3326759A (en) * 1962-07-19 1967-06-20 Lilly Co Eli Antibiotics macrocin and lactenocin
US3344024A (en) * 1963-04-17 1967-09-26 American Cyanamid Co Antibiotic am-684 and method of production
BE667952A (fr) * 1964-08-05
US4161523A (en) * 1972-11-15 1979-07-17 Schering Corporation Rosamicin esters, acid addition salts and methods for production thereof
US4056616A (en) * 1976-03-05 1977-11-01 Schering Corporation Rosamicin derivatives and method of using same
GB1587685A (en) * 1977-03-09 1981-04-08 Microbial Chem Res Found Macrolactone derivatives and their production
US4252898A (en) * 1979-05-23 1981-02-24 Eli Lilly And Company Antibiotics A6888C and A6888X
NL8004922A (nl) * 1979-09-19 1981-03-23 Toyo Jozo Kk Deformyltylosinederivaten.

Also Published As

Publication number Publication date
HU190360B (en) 1986-08-28
IL64240A (en) 1985-08-30
EP0052005B1 (fr) 1985-01-30
FI813527L (fi) 1982-05-11
CS236663B2 (en) 1985-05-15
EP0052005A1 (fr) 1982-05-19
PT73947B (en) 1983-11-30
CA1169374A (fr) 1984-06-19
DD202032A5 (de) 1983-08-24
JPS57108097A (en) 1982-07-05
PT73947A (en) 1981-12-01
PH17375A (en) 1984-08-06
ZA817718B (en) 1982-10-27
GB2086902B (en) 1985-06-26
KR830007833A (ko) 1983-11-07
PL233747A1 (fr) 1982-11-22
IL64240A0 (en) 1982-02-28
US4304856A (en) 1981-12-08
GB2086902A (en) 1982-05-19
AR227563A1 (es) 1982-11-15
DE3168693D1 (en) 1985-03-14
KR850001666B1 (ko) 1985-11-13
IE51826B1 (en) 1987-04-01
IE812616L (en) 1982-05-10
GR75386B (fr) 1984-07-13
DK494381A (da) 1982-05-11
AU7731381A (en) 1982-05-20

Similar Documents

Publication Publication Date Title
BG40654A3 (en) Method for preparing cycloalkyltriazoles
BG40651A3 (en) Method for preparing (1- arylcyclobutyl) alkylamines
BG40655A3 (en) Method for preparing n- (bi heterocyclic)- 4- piperidineamines
BG38787A3 (en) Method for preparing carboxyalkyl dipeptides
BG40142A3 (en) Method for preparing piperazine derivatives
BG37378A3 (en) Method for preparing acylated benzothiophens
BG39297A3 (en) Method for preparing bis- ester of methanediol
BG40815A3 (en) Method for preparing peptides
BG32850A3 (en) Method for obtaining of 6 a, 10 a- cis- hexahydrodibenzopyranols
BG35330A3 (en) Method for preparing 3- iodine- methylcephalosporines
BG42185A3 (en) Method for preparing pyridylic compounds
IT8105203A0 (it) Macchina utensile.
BG39976A3 (en) Method for preparing benzamides
BG42355A3 (en) Method for preparing aminoguanidinic derivatives
BG36939A3 (en) Method for preparing macrolide
BG36928A3 (en) Method for preparing pharmacologically active peptides
BG40807A3 (en) Method for preparing n- phenylcarbamates
BG36932A3 (en) Method for preparing 1- (3- hydroxy- 4- metaxybenzoil)- 3- hydroxy- 2- pyrolidinone
BG40147A3 (en) Method for preparing heterocyclic compounds
RO84099A (fr) Procede d'obtenir 1,2,5-o0adiazole-2-o0ydes
BG28064A3 (en) Method of obtaining of 2,6-methane-2h-1-benzoxozines
BG38940A3 (en) Method for preparing penicillanoyloxymethyl penicillanate- 1, 1- dioxide
BG38337A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
BG40143A3 (en) Method for preparing acetamide derivatives
BG35045A3 (en) Method for preparing substituted triarylthiazolic compounds